Florida HB 309: Rural Emergency Hospitals
Status: Laid on Table, companion bill(s) passed, see CS/SB 644 (Ch. 2024-201) (as of 2024-03-05)
State: Florida · Session: 2024 · Bill: HB 309
Subjects: social welfare, subject index
Sponsors: Select Committee on Health Innovation, Shoaf, Barnaby, Franklin, López, J., Rudman, Tant
Bill Text
CS/CS/HB 309 2026 CODING: Words stricken are deletions; words underlined are additions. hb309-02-c2 Page 1 of 49 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S A bill to be entitled 1 An act relating to controlled substances; amending s. 2 893.03, F.S.; excepting from the list of Schedule I 3 controlled substances certain xylazine animal drug 4 products approved by the United States Food and Drug 5 Administration and used for certain purposes; amending 6 s. 893.13, F.S.; providing criminal penalties and 7 requiring a mandatory minimum term of imprisonment if 8 a person sells, manufactures, or delivers or possesses 9 with intent to sell, manufacture, or deliver xylazine; 10 amending s. 893.135, F.S.; creating the offense of 11 trafficking in xylazine; providing criminal penalties 12 and requiring a mandatory minimum term of imprisonment 13 and fines based on the quantity of the controlled 14 substance involved in the offense; providing effective 15 dates. 16 17 Be It Enacted by the Legislature of the State of Florida: 18 19 Section 1. Effective July 1, 2026, paragraph (c) of 20 subsection (1) of section 893.03, Florida Statutes, is amended 21 to read: 22 893.03 Standards and schedules.—The substances enumerated 23 in this section are controlled by this chapter. The controlled 24 substances listed or to be listed in Schedules I, II, III, IV, 25 CS/CS/HB 309 2026 CODING: Words stricken are deletions; words underlined are additions. hb309-02-c2 Page 2 of 49 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S and V are included by whatever official, common, usual, 26 chemical, trade name, or class designated. The provisions of 27 this section shall not be construed to include within any of the 28 schedules contained in this section any excluded drugs listed 29 within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 30 Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 31 Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 32 Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 33 Anabolic Steroid Products." 34 (1) SCHEDULE I.—A substance in Schedule I has a high 35 potential for abuse and has no currently accepted medical use in 36 treatment in the United States and in its use under medical 37 supervision does not meet accepted safety standards. The 38 following substances are controlled in Schedule I: 39 (c) Unless specifically excepted or unless listed in 40 another schedule, any material, compound, mixture, or 41 preparation that contains any quantity of the following 42 hallucinogenic substances or that contains any of their salts, 43 isomers, including optical, positional, or geometric isomers, 44 homologues, nitrogen-heterocyclic analogs, esters, ethers, and 45 salts of isomers, homologues, nitrogen-heterocyclic analogs, 46 esters, or ethers, if the existence of such salts, isomers, and 47 salts of isomers is possible within the specific chemical 48 designation or class description: 49 1. Alpha-Ethyltryptamine. 50 CS/CS/HB 309 2026 CODING: Words stricken are deletions; words underlined are additions. hb309-02-c2 Page 3 of 49 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-51 oxazoline). 52 3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 53 4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 54 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 55 6. Bufotenine. 56 7. Cannabis. 57 8. Cathinone. 58 9. DET (Diethyltryptamine). 59 10. 2,5-Dimethoxyamphetamine. 60 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 61 12. DMT (Dimethyltryptamine). 62 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 63 analog of phencyclidine). 64 14. JB-318 (N-Ethyl-3-piperidyl benzilate). 65 15. N-Ethylamphetamine. 66 16. Fenethylline. 67 17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 68 18. Ibogaine. 69 19. LSD (Lysergic acid diethylamide). 70 20. Mescaline. 71 21. Methcathinone. 72 22. 5-Methoxy-3,4-methylenedioxyamphetamine. 73 23. PMA (4-Methoxyamphetamine). 74 24. PMMA (4-Methoxymethamphetamine). 75 CS/CS/HB 309 2026 CODING: Words stricken are deletions; words underlined are additions. hb309-02-c2 Page 4 of 49 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S 25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 76 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 77 27. MDA (3,4-Methylenedioxyamphetamine). 78 28. JB-336 (N-Methyl-3-piperidyl benzilate). 79 29. N,N-Dimethylamphetamine. 80 30. Parahexyl. 81 31. Peyote. 82 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 83 analog of phencyclidine). 84 33. Psilocybin. 85 34. Psilocyn. 86 35. Salvia divinorum, except for any drug product approved 87 by the United States Food and Drug Administration which contains 88 Salvia divinorum or its isomers, esters, ethers, salts, and 89 salts of isomers, esters, and ethers, if the existence of such 90 isomers, esters, ethers, and salts is possible within the 91 specific chemical designation. 92 36. Salvinorin A, except for any drug pr
View Florida HB 309 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.